Low Dose Birth Control for Perimenopause: 10 vs 20 mcg, Safety, and Cost

Educational research. Not medically reviewed by a clinician. Not medical advice.

Low dose birth control for perimenopause can be a good option when you still need contraception and estrogen is appropriate for your history. Age alone is not a reason to stop. Migraine with aura, smoking after 35, high blood pressure, current breast cancer, clot history, and new unexplained bleeding can change the answer.^[1][6]

Here is the part almost nobody tells you: “low dose” is low for contraception. It is not the same thing as a low menopause-hormone-therapy dose.

But do not replace one oversimplification with another. The neat charts that call a 10-mcg pill “twice as strong as HRT” and a 20-mcg pill “four times as strong” are false precision. Ethinyl estradiol and estradiol are different drugs with different metabolism, liver effects, tissue effects, routes, and purposes. There is no single conversion that turns contraceptive ovarian suppression, symptom control, clotting effects, and an HRT dose into one honest multiplier.^[7]

That is not a reason to fear the pill. It is a reason to ask the right question.

The right question is not, “What is the lowest number on the box?” It is:

Do I still need contraception, is estrogen medically appropriate for me, and which pill structure fits the problem I am actually trying to solve?

Best for you if

• You still need reliable birth control and want steadier bleeding or fewer hormone-withdrawal swings—one method, two jobs.
• Your periods have become heavy, unpredictable, or both, and that is the problem wrecking your month.
• You want to understand the exact pill class, dose, active days, placebo days, missed-pill rule, and cost before you say yes.
• Your blood pressure and medical history make the selected method appropriate.

Not for you if

• You get migraine with aura. CDC rates combined hormonal contraception category 4—an unacceptable health risk—at any estrogen dose. A 10-mcg pill is not a loophole.^[1]
• You smoke and are 35 or older. Combined hormonal contraception is category 3 below 15 cigarettes per day and category 4 at 15 or more.^[1]
• Your blood pressure is high or treated. Adequately controlled hypertension and blood pressure of 140–159/90–99 are category 3; blood pressure of at least 160/100 is category 4 for combined hormonal contraception.^[1]
• You have current breast cancer. Both combined pills and progestin-only pills are category 4.^[1]
• You have a current or previous blood clot, a thrombophilia, stroke, or significant cardiovascular history. The answer depends on the exact condition and recurrence risk; this is not a self-screening decision.^[1]
• You no longer need contraception. Then you are asking a hormone-therapy question, not just a birth-control question. Start with birth control vs HRT for perimenopause.
• Your bleeding is new, unusually heavy, persistent, or unexplained. That gets evaluated first, not automatically suppressed first.^[6]

Key numbers, upfront

• 10 mcg of ethinyl estradiol is the lowest estrogen amount in a currently approved combined oral contraceptive regimen in the United States.^[10][9]
• 20 mcg appears in many common combined-pill formulations and generics.
• June 22, 2026: FDA approved Lo Junel Fe, an AB-rated generic to Lo Loestrin Fe. Any page still saying the 10-mcg pill has no FDA-approved generic is outdated.^[9]
• 7 in 100: CDC’s typical-use first-year pregnancy estimate for both combined hormonal contraception and progestin-only pills.^[2][3]
• 3 hours versus 48 hours: the missed-pill fork between traditional norethindrone/norgestrel progestin-only pills and drospirenone-only pills.^[3]
• $19.99: Opill’s published price for a 28-tablet OTC pack when checked August 31, 2026. Retailer prices can differ.^[16]

Start here: four situations, four different first questions

Your situation	The first question to ask
You still need birth control, and estrogen may be appropriate	“Could a low-dose combined pill handle both contraception and my worst symptom?”
You still need birth control, but estrogen may be inappropriate	“Which estrogen-free method fits my history and how reliably I take pills?”
You do not need birth control anymore	“Would menopause hormone therapy, local treatment, or a nonhormonal option target this more directly?”
You have new heavy bleeding or a major safety flag	“Should I be assessed in person before anyone changes my hormones?”

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

---

Is low-dose birth control actually a good option in perimenopause?

Yes, it can be when you still need contraception and your history makes the selected method appropriate. CDC classifies combined hormonal contraception as category 2 based on age alone at 40 and older, while progestin-only pills are category 1; CDC also says combined hormonal contraception can be used until menopause in the absence of other adverse clinical conditions.^[1]

Age alone is not the answer. Your blood pressure, smoking, migraine type, clot history, cancer history, bleeding pattern, medications, and need for pregnancy prevention are the answer.

That distinction matters because women are still being moved on or off contraception with too little explanation. A 2022 BMJ Open qualitative study interviewed 14 women ages 40–52. Participants reported that clinicians sometimes recommended method changes based on age alone, while many were largely unaware that hormonal contraception could also be used to manage perimenopausal symptoms.^[8]

Fourteen women cannot tell us how common that experience is. They can tell us the decision friction is real.

If someone handed you “the pill” without explaining the class, dose, placebo interval, safety screen, or transition plan, you are not overthinking this. The pill is not one decision. It is several decisions hidden inside one prescription.

The Menopause Society says continuous-combined hormonal contraception—pill, patch, or ring—is frequently used during perimenopause when contraception and control of hot flashes or night sweats are both needed. It also names a levonorgestrel IUD plus estrogen therapy as another clinician-managed route.^[6]

That does not make every pill right for every woman. It makes the following sequence the useful one:

1. 1. Do you still need pregnancy prevention?
2. 2. Is estrogen appropriate for your history?
3. 3. What is the one symptom or practical problem you most need the method to solve?
4. 4. How reliably can you take a daily pill?
5. 5. Does the active/placebo schedule fit the week your symptoms return?
6. 6. What is the follow-up and eventual transition plan?

Does that sound like your situation? Use Find My HRT Path to identify your safest starting branch—combined contraception, an estrogen-free method, an HRT-first question, or in-person assessment first.

Private decision support. Not a diagnosis, prescription, or confirmation of eligibility.

---

What does low dose birth control for perimenopause actually mean?

“Low dose” usually refers to the estrogen amount in a combined pill, not the pill’s total biological effect and not the milligram number on a progestin-only pill. CDC’s combined-pill guidance covers formulations containing no more than 35 mcg of ethinyl estradiol, but 10-, 20-, 30-, and 35-mcg products are not interchangeable decisions.^[2]

What the number on the package is actually measuring

Number you may see	What it measures	What it does not tell you by itself
10 mcg ethinyl estradiol	Estrogen in each relevant active tablet in Lo Loestrin Fe and its FDA-approved generic reference	Whether estrogen is safe for you, whether you will spot, whether your symptoms will improve, or what the pill will cost at your pharmacy
20 mcg ethinyl estradiol	Estrogen in many common combined pills	Whether a 21/7 or 24/4 schedule will fit you better, or whether a different progestin would be a better match
30–35 mcg ethinyl estradiol	Estrogen in other combined pills still covered by CDC’s COC guidance	That the pill is automatically “too high” or inappropriate; the condition-based safety screen still controls the answer
0.35 mg norethindrone	Progestin in a traditional estrogen-free pill	A comparison with 10 or 20 mcg of estrogen; these are different molecules and different units
4 mg drospirenone	Progestin in Slynd, an estrogen-free pill	That it is “200 times stronger” than a 20-mcg combined pill; the numbers are not on one scale

Ethinyl estradiol is not estradiol with a smaller decimal point

Most conventional combined birth-control pills use ethinyl estradiol, a synthetic estrogen designed for oral contraceptive use. Most menopause hormone therapy uses estradiol, available in oral and transdermal forms.

They are not the same drug at different strengths. A 2024 review describes ethinyl estradiol as having high estrogenic potency with marked hepatic effects, including effects on globulins and coagulation factors; estradiol has different pharmacology, metabolism, and route-dependent effects.^[7]

So keep the damaging admission and throw away the fake math:

A low-dose birth-control pill is not a low-dose HRT product. But there is no honest universal “2×” or “4×” conversion between them.

The job is different, too. A contraceptive regimen is designed to prevent pregnancy. Menopause hormone therapy is designed to treat product-specific menopause indications and does not provide contraception.

FDA-label boundary

Every pill compared on this page is an FDA-approved contraceptive product. None is FDA-approved specifically to treat perimenopause.

Using a contraceptive to address bleeding or hormone-linked symptoms during perimenopause may be a clinician-supported, off-label treatment decision. That is legal and common. It still deserves to be named accurately.

Nothing in this guide is compounded. Compounded hormones are a different regulatory category and are never presented here as equivalent to FDA-approved contraceptives.

---

Is 10 mcg better or safer than 20 mcg?

Not automatically. A 10-mcg combined pill does not change a CDC contraindication, CDC’s missed-pill evidence does not directly compare 10 versus 20 mcg, and FDA’s June 2026 approval of a 10-mcg generic has changed the old brand-only cost story. “Lowest” and “best” are not synonyms.

Reason one: the safety line does not move with the dose

Migraine with aura is category 4 for combined hormonal contraception. So is smoking at age 35 or older when the person smokes at least 15 cigarettes per day. Severe hypertension is category 4. A 10-mcg pill does not turn those into category 2 decisions.^[1]

The safety screen looks at you, not just the foil pack.

Reason two: the missed-pill evidence is narrower than consumer pages make it sound

CDC reviewed studies comparing missed pills containing 20 mcg versus 30 mcg of ethinyl estradiol. Those studies found more follicular activity after missed 20-mcg pills.^[2]

That is useful—but it is indirect evidence about ovarian activity. It is not proof that:

• a 10-mcg pill fails more often than a 20-mcg pill;
• everyone should choose 30 mcg;
• higher estrogen is always more effective or better tolerated; or
• a late pill can be ignored if the dose is higher.

The honest practical takeaway is simpler:

If you regularly miss pills, “the lowest dose” may be the wrong variable to optimize. Ask whether a method with less timing friction would fit you better.

Reason three: the generic landscape changed in June 2026

For years, the 10-mcg regimen had no FDA-approved generic. That changed in June 2026.

FDA’s June 2026 Orange Book update lists Lo Junel Fe, made by Teva, as an AB-rated generic to Lo Loestrin Fe, approved June 22, 2026.^[9]

That correction changes three things:

1. 1. “No generic exists” must be removed from every current price and insurance argument.
2. 2. A brand-specific appeal based on the absence of a therapeutic equivalent is no longer reliable.
3. 3. Current coupon pages may lag behind FDA’s record.

As of August 31, 2026, we could verify the FDA approval. We could not verify stable nationwide pharmacy stock or a reliable national cash-price benchmark for Lo Junel Fe. Ask your pharmacy to search the exact name and your insurer to check its formulary rather than assuming it is already stocked everywhere.

The honest verdict

A 10-mcg product may fit a woman who is medically eligible, takes it consistently, understands the bleeding profile, and can access it at a workable cost. A 20-mcg generic may be the more practical answer for someone whose formulary covers it, whose clinician prefers its regimen, or who wants a 24/4 schedule without brand-level pricing.

The smallest estrogen number can matter. It just does not get to make the entire decision by itself.

---

Does the hormone-free interval matter more than the estrogen dose?

It can matter enormously. CDC says combined hormonal contraceptives are generally used for 21–24 active days followed by 4–7 hormone-free days, and may also be used with infrequent or no hormone-free days. Shorter breaks improve ovarian suppression; if your symptoms return during the placebo days, that pattern is worth taking to your clinician.^[2]

Ask yourself one question:

Is your worst week the placebo week?

If hot flashes, headaches, bleeding, or a mood crash arrive like clockwork when the active tablets stop, you may be focusing on the wrong number. The useful discussion may be about shortening or removing the hormone-free interval—not automatically changing from 20 to 10 mcg.

Do not overstate the evidence. CDC’s review supports stronger ovarian suppression with shorter hormone-free intervals. That does not guarantee that a shorter break will fix your symptoms. It gives you a specific, testable pattern to discuss.

Representative pack structures

Structure	Hormone exposure across the pack	Representative product	What it may mean practically
21 active / 7 nonhormonal	21 combination tablets, then 7 iron/placebo tablets	Junel Fe 1/20 and comparable 21/7 products	Longest scheduled hormone-free interval in this comparison; symptoms may return during that week in some users
24 active / 4 nonhormonal	24 combination tablets, then 4 inert tablets	Junel Fe 24; Yaz and generics	Shorter scheduled break than 21/7
26 hormone-containing / 2 nonhormonal	24 combination tablets, 2 estrogen-only tablets, then 2 nonhormonal tablets	Lo Loestrin Fe; FDA-approved generic reference Lo Junel Fe	Only 2 truly hormone-free days, but spotting and absent withdrawal bleeding remain material considerations
24 active / 4 inactive, estrogen-free	24 drospirenone-only tablets, then 4 inert tablets	Slynd	An estrogen-free prescription path with a different missed-pill rule and product-specific potassium/renal/adrenal cautions
Continuous or extended combined use	Infrequent or no hormone-free interval	Product and plan selected by a clinician	Fewer scheduled withdrawal bleeds; unscheduled bleeding can occur, especially early

Representative products only. Pack instructions, substitution, and extended-use plans must be confirmed from the exact label and clinician instructions.^{[10][13][14][11]}

One sentence to take to the appointment

“Before we change the estrogen dose, could the number of hormone-free days be the reason my symptoms return?”

That question is specific enough to earn a useful answer.

If your worst week is the placebo week, use Find My HRT Path to build the regimen questions that fit your pattern.

---

Which low-dose birth-control pills can you actually get now?

The useful comparison is not a ranked list of brand names. It is the pill class, exact ingredients, active/placebo schedule, FDA-labeled use, missed-pill rule, generic status, and the limitation that would matter to you. FDA approved a 10-mcg generic in June 2026, but its real-world stock and price were not yet stable enough to quote.

The HRT Index low-dose pill label-and-fit matrix

Representative product	Class and active schedule	FDA-labeled use	Why it may enter a perimenopause discussion	Material catch
Lo Loestrin Fe	Combined pill: 24 tablets with norethindrone acetate 1 mg + ethinyl estradiol 10 mcg; 2 tablets with 10 mcg ethinyl estradiol; 2 nonhormonal tablets	Prevent pregnancy	A 10-mcg EE reference with only 2 fully hormone-free days	Still a combined hormonal contraceptive. Its label trial enrolled ages 18–35 and did not evaluate efficacy at BMI over 35. Spotting and absent withdrawal bleeding were common.[10]
Lo Junel Fe	FDA-approved AB-rated generic to Lo Loestrin Fe	Prevent pregnancy	The first FDA-approved generic reference for the 10-mcg regimen	Approved June 22, 2026; stable national stock and price could not yet be verified on August 31, 2026.[9]
Junel Fe 1/20	Combined pill: 21 tablets with norethindrone acetate 1 mg + ethinyl estradiol 20 mcg; 7 nonhormonal iron tablets	Prevent pregnancy	A common 20-mcg generic benchmark	Seven-day hormone-free interval; exact manufacturer, inactive ingredients, formulary status, and pack instructions matter.[11]
Junel Fe 24 or comparable 24/4 norethindrone-acetate product	Combined pill: 24 tablets with norethindrone acetate 1 mg + ethinyl estradiol 20 mcg; 4 nonhormonal tablets	Prevent pregnancy	A 20-mcg combined option with a shorter scheduled break	Still uses the full combined-pill safety screen; “24/4” is not a contraindication workaround.[12]
Yaz or a label-matched generic	Combined pill: 24 tablets with drospirenone 3 mg + ethinyl estradiol 20 mcg; 4 inert tablets	Prevent pregnancy; PMDD treatment only for patients choosing an oral contraceptive for contraception; moderate acne under label conditions	Relevant when contraception plus diagnosed PMDD or acne is an actual goal	Renal/adrenal issues, thrombotic risk, potassium-related interactions, and the difference between PMDD and ordinary perimenopausal mood changes matter.[13]
Norethindrone 0.35 mg	Progestin-only pill: 28 active tablets, no estrogen	Prevent pregnancy	Estrogen-free prescription contraception	More than 3 hours late counts as a missed pill under CDC guidance; irregular bleeding is common.[3]
Opill, norgestrel 0.075 mg	OTC progestin-only pill: 28 active tablets, no estrogen	Prevent pregnancy	Nonprescription estrogen-free access	More than 3 hours late matters; the label says not to use it with current or previous breast cancer. It is not a perimenopause-symptom product.[15]
Slynd, drospirenone 4 mg	Prescription progestin-only pill: 24 active tablets + 4 inert tablets	Prevent pregnancy	Estrogen-free option with a more forgiving missed-pill protocol than traditional POPs	Contraindicated with renal impairment, adrenal insufficiency, certain hormone-sensitive cancers, hepatic impairment, or undiagnosed bleeding; potassium monitoring may be required with certain medicines.[14]

A pharmacy-name warning that can save you a panic spiral

Several products may list the same active ingredients and strength under different manufacturer names. That does not mean every box, pack schedule, inactive ingredient, or substitution is identical.

If the pharmacy hands you a new name, ask:

“Please confirm the active ingredients, strengths, number of active tablets, and number of placebo tablets match my prescription.”

Do not compare milligrams with micrograms as if they are one strength ladder. For the deeper progestin explanation, see norethindrone for perimenopause.

---

Can you take low-dose birth control in your 40s and 50s?

Age alone does not disqualify you. CDC places age 40 and older in category 2 for combined hormonal contraception and category 1 for progestin-only pills, but the answer can change sharply with aura, smoking, blood pressure, clot history, breast cancer, or several cardiovascular risk factors together.^[1]

CDC uses four categories:

• Category 1: no restriction.
• Category 2: advantages generally outweigh theoretical or proven risks.
• Category 3: risks usually outweigh advantages.
• Category 4: unacceptable health risk if the method is used.

The low-dose safety screen

Health factor	Progestin-only pill	Combined pill, patch, or ring	What it means in plain English
Age 40 or older, without another listed condition	1	2	Age alone is not a reason to stop.
Migraine without aura	1	2*	A combined method may be discussed, but the classification assumes no additional stroke-risk factors.
Migraine with aura	1	4	A 10-mcg pill is not a loophole.
Age 35+ and smoking fewer than 15 cigarettes/day	1	3	A combined method usually should not be the default.
Age 35+ and smoking 15 or more cigarettes/day	1	4	Do not use combined hormonal contraception.
Adequately controlled hypertension	1	3	“Controlled” does not make a combined pill category 1.
Blood pressure 140–159/90–99	1	3	A clinician should usually move away from combined hormonal contraception.
Blood pressure at least 160/100	2	4	Combined hormonal contraception is an unacceptable-risk category; the blood pressure itself needs care.
BMI of 30 or higher, by itself	1	2	Not an automatic disqualifier, but other clot and cardiovascular factors still matter.
Current breast cancer	4	4	“Estrogen-free” does not make a progestin-only pill acceptable here.
Past breast cancer, disease-free for 5 years	3	3	Usually avoid hormonal contraception; coordinate with the oncology team.
Current or previous DVT/PE	Usually 2, depending on scenario	3 or 4, depending on recurrence risk and anticoagulation	This needs clinician classification, not a generic online yes/no.
Known thrombophilia	2	4	Combined hormonal contraception is not the route.
Suspicious unexplained vaginal bleeding before evaluation	2	2	The category does not mean the bleeding should be ignored. Evaluate it first.

Source: CDC, U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. This is a screening summary, not a determination of personal eligibility.^[1]

The two CDC clarifications worth remembering

The categories are not points you simply add. Two category-2 factors do not mechanically become category 4. But several major cardiovascular risk factors together can still make combined contraception an unacceptable choice. That is clinical judgment, not arithmetic.^[1]

The estrogen number does not rewrite a category. A category-4 condition does not become category 2 because the pill says 10 mcg.

When bleeding changes the order of operations

Perimenopause commonly changes cycle timing and flow. It also does not explain every new bleeding pattern. The Menopause Society advises assessment when a woman notices a meaningful change in her usual pattern.^[6]

Get emergency care, not an article: ACOG advises emergency care if you are changing pads or tampons every hour for more than 2 hours and have chest pain, shortness of breath, lightheadedness, or dizziness.^[18]

Heavy bleeding without those symptoms still deserves prompt clinical assessment, especially when it is new, persistent, or causing weakness.

Want to know which rows may change your starting point? Use Find My HRT Path before you pay for an online visit. The result can tell you when in-person care belongs first.

---

What if estrogen is off the table?

Estrogen-free options remain available for many women, but “no estrogen” does not mean “no contraindications.” Traditional norethindrone and norgestrel pills have a 3-hour missed-pill rule, drospirenone has a different protocol, and current breast cancer is category 4 for progestin-only pills.^[1][3]

Norethindrone 0.35 mg

This is the traditional prescription mini-pill. CDC explains that norethindrone and norgestrel POPs inhibit ovulation in about half of cycles and also work through cervical-mucus and other effects. That helps explain why timing matters so much.^[3]

Norgestrel 0.075 mg: Opill

Opill is FDA-approved for over-the-counter daily contraception. It requires no prescription and no telehealth visit. The current Drug Facts label says to take one tablet at the same time every day, no later than 3 hours from the prior day’s time, with no break between packs. It says not to use the product with current or previous breast cancer.^[15]

The manufacturer’s online store listed a 28-tablet pack at $19.99 on August 31, 2026.^[16]

We earn nothing when you buy it. For some readers, it is still the right access answer.

Drospirenone 4 mg: Slynd

Slynd is a prescription progestin-only pill with 24 active and 4 inactive tablets. Its primary contraceptive mechanism is ovulation suppression. The label lists renal impairment, adrenal insufficiency, certain hormone-sensitive cancers, hepatic impairment, and undiagnosed abnormal uterine bleeding as contraindications. It also carries a hyperkalemia warning for people taking medicines that can raise potassium.^[14]

The missed-pill difference is the practical fork

Pill type	CDC counts it as missed when	What CDC says about backup contraception
Norethindrone or norgestrel POP	More than 3 hours late	Take the pill as soon as possible, continue daily, and use condoms or abstain until pills have been taken correctly and on time for 2 consecutive days.
Drospirenone POP	At least 48 hours since a pill should have been taken	Take the most recent missed pill, continue daily, and use condoms or abstain until pills have been taken for 7 consecutive days. A pill less than 48 hours late does not require backup under CDC guidance.
Combined pill	One pill less than 48 hours late generally does not require backup; 2 or more consecutive active pills missed means at least 48 hours	Continue the pack as directed and use condoms or abstain until active pills have been taken for 7 consecutive days. Instructions change depending on where the missed pills fall in the pack.

Follow the current instructions for your exact product. Vomiting, severe diarrhea, interacting medicines, emergency contraception, or several missed tablets can change what to do.^[3][2]

A 3-hour window versus a 48-hour threshold is not a technicality. It may be the whole decision for someone who regularly remembers a pill at lunch instead of breakfast.

The option no telehealth page can place for you

A 52-mg levonorgestrel IUD is worth a separate conversation when heavy bleeding and contraception are both major goals. The Menopause Society also notes that a levonorgestrel IUD can be combined with estrogen therapy in a clinician-managed plan during perimenopause.^[6]

It requires an in-person placement. If heavy bleeding is your headline problem, an OB-GYN, reproductive-health clinic, or community health center may be a better first stop than any pill-subscription service.

---

What does low-dose birth control actually do for perimenopause symptoms?

Combined hormonal contraception can be useful when pregnancy prevention and symptom control are both needed, especially for cycle control and some vasomotor symptoms. It is not a universal treatment for mood, sleep, brain fog, libido, or vaginal symptoms, and the representative products on this page are not FDA-approved specifically for perimenopause.^[6]

Symptom-to-question matrix

Your actual goal	The next useful question	Honest read
Contraception plus hot flashes or night sweats	“Is combined hormonal contraception appropriate for me, and would a shorter or continuous regimen fit the timing of my symptoms?”	The Menopause Society says continuous-combined contraception is frequently used when birth control is also needed.[6]
Contraception plus irregular or heavy bleeding	“Does this bleeding need evaluation first, and if not, which method best fits the pattern?”	Cycle control is a common reason to use hormonal contraception, but new or concerning bleeding should not be dismissed as perimenopause.
Symptoms return during the placebo week	“Before changing the dose, can we shorten or remove the hormone-free interval?”	Shorter breaks improve ovarian suppression; symptom response is individual.[2]
Contraception plus diagnosed PMDD	“Does a drospirenone/ethinyl-estradiol product with the conditional PMDD indication fit my health history?”	The Yaz label covers PMDD only for patients choosing an oral contraceptive for contraception.[13]
Contraception plus moderate acne	“Does a label-matched acne indication fit my age, goals, and risks?”	The indication is product-specific and conditional on wanting oral contraception.[13]
Menstrual migraine without aura	“Is it definitely without aura, and do I have any other stroke-risk factors?”	Migraine without aura is category 2 only within the full risk context.[1]
Migraine with aura	“Which estrogen-free or nonhormonal method fits me?”	Combined hormonal contraception is category 4.[1]
Vaginal dryness, painful sex, or urinary symptoms	“Would a local treatment be more targeted than changing an oral contraceptive?”	An oral birth-control pill is not the targeted default for genitourinary syndrome of menopause.
Mood, sleep, brain fog, or libido	“What other causes need checking, and what outcome will we track after starting?”	Some women feel better, some worse, and no pill can honestly promise the result.
No current need for contraception	“Would HRT, local therapy, or a nonhormonal treatment target this more directly?”	Use the dedicated birth control vs HRT guide.

One thing we will not say: that a pill will “fix your perimenopause.”

It may fix the specific thing wrecking your month. Name that thing before the appointment. “I feel awful” and “I bleed for 9 days and miss work” should not produce the same unexamined prescription.

---

What side effects and warning signs should you expect?

Spotting, absent withdrawal bleeding, headache, nausea, breast tenderness, mood changes, and other effects vary by formulation and person. Ultra-low estrogen does not guarantee a symptom-free first few months, and the best published bleeding numbers for Lo Loestrin Fe came from women ages 18–35—not a perimenopause-specific trial.^[10]

What the Lo Loestrin Fe label actually found

In the product’s 12-month clinical trial:

• 85.9% of participants experienced unscheduled bleeding or spotting at some point during cycles 2–13.
• The proportion reporting unscheduled bleeding or spotting declined from 53% in cycle 2 to 36% in cycle 13.
• Amenorrhea increased from 32% in cycle 1 to 49% by cycle 13.^[10]

Those numbers are useful because they make the tradeoff visible. They are not perimenopause outcome estimates: the trial enrolled women ages 18–35, and efficacy was not evaluated in women with BMI over 35.^[10]

That is a damaging admission worth keeping:

The lowest-estrogen combined pill can still produce a lot of spotting and no scheduled bleed at all. “Ultra-low” does not mean “nothing happens.”

Breakthrough bleeding on continuous or extended regimens

CDC says spotting or bleeding is common during the first 3–6 months of extended or continuous combined-hormonal-contraceptive use and generally decreases with continued use. For bothersome bleeding, CDC describes a clinician-directed 3–4-day hormone-free interval as one possible management option—but not during the first 21 days of use and not more than once per month because contraceptive effectiveness may be reduced.^[2]

That is something to ask about. It is not something to improvise.

Weight and mood

No one can guarantee that a pill will or will not change your weight, appetite, fluid retention, or mood. CDC says baseline weight and BMI are not required to establish eligibility but may be useful for discussing changes later.^[4]

Write down:

• your starting weight if weight change concerns you;
• your bleeding days;
• your worst symptom;
• the day of the pack when it happens; and
• any new headache, aura, mood, or blood-pressure change.

That turns “I think I feel different” into information a clinician can use.

The cancer tradeoffs, without cherry-picking

The National Cancer Institute says most evidence is observational, so it cannot prove that oral contraceptives caused or prevented a particular cancer outcome. Across the evidence it summarizes:

• current oral-contraceptive use has been associated with a modest increase in breast-cancer risk, which declines after stopping and was no longer evident by 10 years in one large pooled analysis;
• recent combined-hormonal-contraceptive use was associated with about a 20% relative increase in a large Danish cohort, varying by formulation;
• endometrial-cancer risk is at least 30% lower among women who have used oral contraceptives;
• ovarian-cancer risk is 30%–50% lower, with protection reported for decades after stopping; and
• cervical-cancer risk rises with longer use and declines after stopping.^[17]

Do not turn those population associations into a personal guarantee or a scare headline. Current or previous breast cancer changes contraceptive eligibility directly and belongs in a clinician-led decision.^[1]

---

What does low-dose birth control cost in 2026?

Current cash prices depend on the exact product, pharmacy, ZIP code, quantity, insurance, and coupon. The old claim that the 10-mcg regimen has no generic is obsolete: FDA approved Lo Junel Fe in June 2026, but stable nationwide stock and a reliable cash benchmark were not yet verifiable on August 31.^[9]

Price snapshot verified August 31, 2026

Product or route	Published price checked	What the number does—and does not—mean
Brand Lo Loestrin Fe	GoodRx displayed an average retail price around $236.16 and coupon prices from about $99	Third-party coupon snapshot, not a quote. The same page still carried stale “no generic” wording, so generic status came from FDA—not GoodRx.[19]
Junel Fe 1/20	GoodRx displayed an average retail price around $64.25 and a coupon price around $27.99	Pharmacy and ZIP dependent.[20]
Comparable generic norethindrone acetate/EE 1/20 products	GoodRx displayed an average retail price around $50.77 and a coupon price around $27.99	Exact manufacturer and pack matter.[21]
Lo Junel Fe, 10-mcg generic	No reliable national cash benchmark verified yet	FDA approval is confirmed; ask the pharmacy to search the exact product and the insurer to check formulary status.[9]
Opill, 28 tablets	Manufacturer store listed $19.99	OTC product; retailer prices and multipack discounts may differ.[16]
Hers birth-control subscription	Plans advertised from $12/month	Service-specific cash price; the exact pill, cadence, state availability, and total charged are confirmed during the intake.[25]

The plain version

Brand Lo Loestrin Fe can still cost several times more than a common 20-mcg generic in current coupon snapshots. But the reason can no longer be stated as “there is no generic.” There is now an FDA-approved generic, and its entry may change availability, formulary placement, and price over time.

That is exactly why this page uses a dated verification line instead of freezing an old market story into permanent copy.

What insurance is supposed to cover

Most non-grandfathered private health plans are subject to federal preventive-services contraceptive-coverage rules, with religious and other legally recognized exceptions. Actual coverage, formularies, medical-management rules, and exception handling still vary.^[22]

Federal FAQ guidance issued in January 2024 describes a therapeutic-equivalence approach as one way plans can comply: cover without cost sharing each FDA-approved contraceptive drug or drug-led device that lacks a therapeutic equivalent, while maintaining an exceptions process for medically appropriate products.^[23]

The phrase “one way plans can comply” matters. It is not a guarantee that every brand will clear the pharmacy for $0.

The new AB-rated Lo Junel Fe approval also means the old Lo Loestrin Fe appeal template based on “no therapeutic equivalent exists” should not ship.

Copy this instead: a general contraceptive exception request

Request for contraceptive coverage exception

Member name / ID / plan: _______ Product requested: ____ Prescriber: _______

My clinician determined that this specific FDA-approved contraceptive is medically appropriate for me. Please process this request through the plan’s contraceptive exceptions process.

If the request is denied or the product is subject to cost sharing, please provide in writing:

1. the covered alternative the plan considers therapeutically equivalent;
2. the medical-management or formulary criterion used;
3. the exception decision and clinical basis; and
4. the appeal steps and deadline.

No CTA here. Take the script and use it.

---

Does the pill hide menopause?

It can hide the bleeding pattern used to identify menopause, and combined hormonal contraception suppresses FSH. It does not pause ovarian aging or push menopause later. CDC says no reliable laboratory test confirms definitive loss of fertility, so a single hormone panel is not a universal stop signal.^[5]

“Masking” is real

The bleed during a placebo interval is a withdrawal bleed produced by the regimen. It does not prove that your ovaries produced a natural cycle. If the pill removes scheduled bleeding entirely, the calendar cannot show you when the final spontaneous period occurred.

“Delaying” is not

The pill does not preserve eggs or reset ovarian aging. It changes what you can observe while you are taking it.

A blood test does not solve the whole problem

Combined hormonal contraception suppresses FSH, and CDC says no reliable laboratory test is available to confirm definitive loss of fertility. FSH testing may be inaccurate in this setting.^[5]

If your real worry is pregnancy risk, read can you get pregnant during perimenopause?.

---

When should you switch from the pill to menopause hormone therapy?

There is no one switch birthday for every U.S. patient. CDC says contraception is generally continued until menopause or approximately age 50–55, while The Menopause Society says pregnancy remains possible during perimenopause. The transition depends on contraception need, health history, symptoms, and the method you are using—not one FSH result.^[5][6]

The important boundaries are clear:

• Menopause hormone therapy is not contraception.
• A combined birth-control pill and systemic menopause HRT should not be layered or switched on your own.
• Stopping the pill may reveal bleeding or symptoms that the pill had been controlling.
• If contraception is still needed, the transition plan must preserve pregnancy prevention.
• If you have a uterus and later use systemic estrogen, endometrial protection becomes part of the HRT plan.

Five questions for the transition visit

1. 1. Do I still need contraception?
2. 2. Which part of my current pill is treating symptoms, and which part is preventing pregnancy?
3. 3. Should I switch to an estrogen-free or non-pill contraceptive before HRT?
4. 4. What bleeding after the switch would need evaluation?
5. 5. What is the exact date and sequence for stopping one regimen and starting the next?

If you are approaching that decision, get your personalized starting plan in Find My HRT Path before choosing a provider.

---

What should a good birth-control visit include?

Blood pressure is the one examination CDC classifies as essential before starting combined hormonal contraception. A pelvic exam, Pap test, breast exam, glucose, lipids, liver enzymes, hemoglobin, thrombophilia screening, and STI/HIV laboratory screening are not routinely required solely to start a combined pill in an otherwise healthy patient.^[4]

That does not mean “no medical review.” It means the visit should spend its time on the history and measurement that actually change the decision.

CDC’s pre-start checklist for combined hormonal contraception

Examination or test	CDC classification before CHC initiation in an otherwise healthy patient
Blood pressure	Class A—essential and mandatory in all circumstances
Weight / BMI	Not required for eligibility; may be useful as a baseline
Clinical breast examination	Class C
Pelvic examination / cervical inspection	Class C
Glucose	Class C
Lipids	Class C
Liver enzymes	Class C
Hemoglobin	Class C
Thrombophilia screening	Class C
Pap test	Class C
STI screening	Class C
HIV screening	Class C

Class C means the test does not contribute substantially to safe and effective use of the method in an otherwise healthy patient. Known medical problems can still require additional evaluation.^[4]

Why blood pressure is different

Severe hypertension is category 4 for combined hormonal contraception; controlled or moderately elevated hypertension is category 3. CDC also found worse cardiovascular outcomes among users who had not had blood pressure measured before starting a combined pill.^[4]

The honest telehealth limitation

A video visit cannot physically take your blood pressure through the screen. That is a real limitation of online care.

Here is the pivot, and it comes directly from CDC: when a provider cannot measure blood pressure, a reading taken in another setting can be reported by the patient.^[4]

Use a reliable recent reading from a clinic, pharmacy, or validated home monitor. Record the date, the number, and how it was taken. Your prescriber decides whether the reading is recent and reliable enough or needs repeating.

Do not invent a special two-week home protocol because an article said so. The requirement is a credible blood-pressure assessment, not a ritual.

Ask for enough packs

CDC recommends providing or prescribing up to a 1-year supply—13 packs—at the initial and return visit when appropriate. More packs are associated with better continuation and fewer gaps.^[4]

If you receive one pack at a time, ask whether the limit comes from the prescriber, pharmacy, insurer, or subscription cadence.

---

Where can you get low-dose birth control for perimenopause online?

Online care falls into three useful models: a menopause-focused video practice, a cash-pay pill subscription, and a marketplace visit that sends a prescription to your pharmacy. The right model depends on whether you need a broader perimenopause assessment, already know the pill you want, need insurance, or have a safety flag that belongs in person.

Affiliate disclosure: The HRT Index may earn a commission from some provider links on this page. That does not change the prices or limitations we report. Eligibility, the medication prescribed, state availability, and final cost depend on clinician review and current terms.

Provider-stated facts, verified August 31, 2026

Care path	Current published facts	Best fit	Material limits to know before you pay
Midi Health	Virtual menopause-focused care available in all 50 states; in-network with most PPO plans; published self-pay prices of $250 for an initial visit and $150 for continued-care visits. Midi does not accept Medicaid or Medi-Cal, even as self-pay. It does not bill Medicare, but Medicare beneficiaries may self-pay and may not submit claims for Midi-related care.[24]	You want a menopause-focused video visit, insurance may help, and you want contraception considered inside a broader perimenopause and eventual HRT plan	Exact contraceptive prescribing, formulation, pharmacy coverage, and suitability are decided at the visit. A video visit still requires a credible blood-pressure reading for a combined pill.
Hers	Birth-control plans advertise from $12/month, licensed-provider review, free shipping, and automatic refills.[25]	You already know you want a pill-only cash-pay model and the available formulation fits your history	State availability is confirmed during intake. Subscription terms matter. Hers says cancellation should be completed at least 48 hours before the next order date, and an order already processing may not be cancelable.[26] The FTC, Utah, and California filed a pending lawsuit in July 2026 alleging deceptive billing, cancellation, and privacy practices; these are allegations, not a final judgment.[27]
Sesame	One-off online prescription/refill visits show prices from $34 and send an approved prescription to the patient’s chosen pharmacy. Sesame also advertises Everyday Rx at $29/month with an annual plan or $59 month-to-month, with eligible medications priced separately at $1 and delivery included.[28][29]	You want one video visit and your own pharmacy, or you want to compare a refill subscription without using insurance for the visit	Provider, state, appointment, prescription, and medication eligibility vary. A prescription is not guaranteed. Confirm the exact total, renewal cadence, included medication, and cancellation terms before checkout.
Your OB-GYN, primary-care clinician, reproductive-health clinic, or community health center	In-person assessment, examination when needed, blood-pressure measurement, and procedures such as IUD placement	New heavy bleeding, uncertain diagnosis, major cardiovascular/clot/cancer history, or an IUD discussion	Price and access vary, but this is the correct first path when the decision cannot be made safely through a form and video screen.

The provider-specific damaging admission

Midi does not operate like a $12 pill subscription. If the cheapest possible generic shipped with the least interaction is your priority, Hers may fit that model better.

But because Midi sells a scheduled menopause-focused visit rather than only a pill shipment, it may fit a woman who needs the contraception decision tied to bleeding, vasomotor symptoms, risk history, and an eventual HRT transition.

Hers is simpler and cheaper on the front end. The subscription and cancellation terms—and the pending FTC case—are material enough that you should screenshot the price, refill date, and cancellation screen before submitting the intake.

Sesame gives you more control over the visit and pharmacy. It is not one fixed product: the one-off visit and Everyday Rx subscription have different economics, and medication inclusion depends on the program and formulary.

Who should skip the online table and go in person

Start in person if you have:

• migraine with aura and need a new contraceptive plan;
• blood pressure at or above 160/100;
• current breast cancer;
• a significant clot, stroke, cardiovascular, or thrombophilia history;
• unexplained or postmenopausal bleeding;
• new severe or persistent heavy bleeding; or
• a likely IUD or procedural need.

No provider commission is worth routing the wrong woman into the wrong care setting.

Know the care model you need but not the company? Use Find My HRT Path to match the decision before the provider.

---

What do women actually say about this decision?

A testimonial cannot tell you which pill is safe or effective for your history. It can tell you what access felt like, while the medical decision still belongs to the evidence and your clinician.

“Midi was incredibly easy. I signed up and had a visit the next day.” — Katherine G., published by Midi Health^[24]

About access only—not medication results. Published by the provider, not independently verified; individual experiences vary. The HRT Index has an affiliate relationship with Midi.

The stronger evidence for the decision friction itself is the BMJ Open qualitative study of 14 women ages 40–52.

Participants were anxious about unintended pregnancy. Some reported that clinicians recommended a method change based on age alone. They were also experiencing perimenopausal symptoms while remaining largely unaware that hormonal contraception might be used to address some of those symptoms.^[8]

That study is small and cannot tell us how often this happens. It supports the emotional truth behind the search:

Women are being asked to accept a method change without being shown the full decision.

This page exists so you can make that decision out loud.

---

What should you ask before accepting the prescription?

Do not leave the visit with only a brand name. You should know the pill class, exact ingredients, estrogen amount, active/placebo schedule, FDA-labeled purpose, missed-pill rule, expected bleeding pattern, why it fits your goal, which history could make it inappropriate, and when the plan will be reviewed.

The 12-question prescription checklist

1. 1. Is this a combined pill or a progestin-only pill?
2. 2. What are the exact estrogen and progestin ingredients and strengths?
3. 3. How many active days, estrogen-only days, and fully hormone-free days are in the pack?
4. 4. What is this product FDA-approved for?
5. 5. Which one of my goals is this prescription meant to solve?
6. 6. Why this formulation instead of an estrogen-free method, IUD, or different combined regimen?
7. 7. Which parts of my history did you use to decide this is appropriate for me?
8. 8. What was my blood pressure, when was it taken, and is it recent enough?
9. 9. What exactly counts as a missed pill for this product?
10. 10. What bleeding should I expect, and what change should make me call or seek urgent care?
11. 11. Which medicines or supplements could reduce effectiveness or create an interaction?
12. 12. When will we reassess symptoms, side effects, contraception need, and the eventual transition from birth control?

Add these fields beneath the list:

• Blood-pressure reading: ___ / ___
• Date and location of reading: ____________________
• My one primary goal: ____________________
• My worst day of the pill pack: ____________________
• Follow-up date: ____________________

Want the questions generated for your situation instead of staying generic? Build your clinician question list in Find My HRT Path. It takes about 90 seconds and does not require an email.

---

What did The HRT Index actually verify?

This page separates primary-source label facts, clinical guidance, current commercial facts, and editorial conclusions. It does not turn a provider framework into a fake pill score, and it does not present an off-label perimenopause use as an FDA indication.

Read directly for this update

• CDC, U.S. Medical Eligibility Criteria for Contraceptive Use, 2024—the age, migraine, smoking, hypertension, clot, thrombophilia, breast-cancer, obesity, and bleeding categories used in the safety screen.
• CDC, U.S. Selected Practice Recommendations for Contraceptive Use, 2024—blood-pressure requirements, pre-start tests, missed-pill rules, typical-use failure, hormone-free-interval evidence, bleeding management, supply quantity, and transition guidance.
• FDA’s June 2026 Orange Book changes—Lo Junel Fe’s June 22, 2026 approval and AB therapeutic-equivalence rating to Lo Loestrin Fe.
• Current DailyMed labels for Lo Loestrin Fe, Yaz, Slynd, Opill, and representative 20-mcg norethindrone-acetate products.
• The Menopause Society’s current perimenopause guidance.
• The National Cancer Institute’s oral-contraceptive cancer-risk summary.
• Current official provider pages and terms for Midi, Hers, and Sesame.
• The FTC’s July 29, 2026 Hims & Hers case page and complaint summary, which list the case as pending.
• Current third-party price pages for the dated cash-price snapshot.

What we could not verify as a stable fact

• Stable nationwide pharmacy stock for newly approved Lo Junel Fe.
• A reliable national cash-price benchmark for Lo Junel Fe.
• The exact medication any telehealth clinician will prescribe before intake.
• Your plan’s final copay, formulary result, or exception outcome.
• A stable public state-by-state list for Hers birth control or individual Sesame prescribers; both must be confirmed at intake or booking.
• Your individual response to a particular pill.

What we did not do

No diagnosis. No prescription. No determination that you personally are eligible. No first-person medication test. No fabricated medical review. No medication-outcome testimonial. No numeric provider score.

This page is editorial research and is not medically reviewed by a clinician.

How we work

This page follows The HRT Index Verification Standard. For provider research, that means reviewing the same five pillars in the same order: clinical legitimacy, care quality, medication fit, price transparency, access.

We read published prices, keep FDA-approved and compounded options strictly separated, verify material availability and insurance statements, and re-check top providers monthly and the wider roster quarterly. Medication labels and CDC guidance are re-checked quarterly and whenever an update is published. Prices and newly launched generics are re-checked monthly.

---

Frequently asked questions about low dose birth control for perimenopause

Is 10 mcg safer than 20 mcg?

Not in the way most people mean. A smaller estrogen number does not change a CDC category-4 contraindication. CDC found more follicular activity after missed 20-mcg pills than after missed 30-mcg pills, but that is indirect evidence and does not prove a 10-mcg pill fails more often than a 20-mcg pill.^[2]

Is there now a generic for Lo Loestrin Fe?

Yes. FDA’s June 2026 Orange Book update lists Lo Junel Fe, Teva ANDA A219324, as an AB-rated generic to Lo Loestrin Fe, approved June 22, 2026.^[9] Stable national stock and price were not yet verifiable on August 31, 2026.

Can I take a combined pill at 50?

Age alone does not make combined hormonal contraception inappropriate. CDC classifies age 40 and older as category 2 and says CHCs may be used until menopause in the absence of other adverse clinical conditions. Smoking, aura, blood pressure, clot history, cancer history, and other cardiovascular risks may change the answer.^[1]

Will birth control hide menopause?

It can hide the natural bleeding pattern and suppress FSH, which makes a single hormone panel an unreliable way to determine when fertility has ended. It does not delay ovarian aging.^[5]

Do I need progesterone with a combined pill?

No extra progesterone is routinely added to a combined oral contraceptive. The pill already contains a progestin. Do not add systemic HRT or progesterone on your own.

Can I skip the placebo week?

Extended or continuous combined-hormonal-contraceptive use is an established approach, but the plan should match the exact product and clinician instructions. Unscheduled bleeding is common early, and missed-pill rules still matter.^[2]

What if my worst symptoms happen during the sugar pills?

Tell your clinician exactly that. A shorter or continuous regimen may be a more useful discussion than automatically lowering the estrogen dose. CDC’s evidence supports stronger ovarian suppression with shorter hormone-free intervals.^[2]

Will the pill make me gain weight?

No one can promise the answer for an individual. Record a baseline if weight change concerns you, then compare actual measurements rather than memory alone. CDC says baseline weight can be useful for later discussions even though it is not required for eligibility.^[4]

What if I get migraines?

The aura question is decisive. Migraine without aura is category 2 for combined hormonal contraception within the full stroke-risk context; migraine with aura is category 4 at every combined-pill dose.^[1]

Does the pill protect my bones?

CDC notes that combined-pill use may have little effect on bone mineral density in premenopausal adults and may preserve bone mass in some perimenopausal users, but bone-density findings are not a reason by themselves to choose a pill and do not guarantee fewer fractures.^[1]

Does the pill cause blood clots?

Combined hormonal contraception increases clot risk, and the importance of that risk changes with smoking, age, obesity, previous clots, thrombophilia, surgery, and other factors. A current or previous clot can make a combined pill category 3 or 4 depending on the scenario.^[1]

Is low-dose birth control covered by insurance?

Many non-grandfathered private plans must cover contraceptive preventive services without cost sharing, subject to current federal rules, plan medical management, and lawful exceptions. A specific brand is not automatically guaranteed at $0. Use the plan’s contraceptive exceptions process when your clinician determines a nonpreferred product is medically appropriate.^[22][23]

Can I get birth control without a prescription?

Opill, containing norgestrel 0.075 mg, is available over the counter. Other pills discussed on this page require a prescription, though the prescriber may be online where available.^[15]

What happens when I stop the pill?

The pill’s cycle control ends, fertility can return, and the bleeding or symptoms it was suppressing may reappear. Stopping does not instantly prove menopause, and HRT is not contraception. Make a transition plan before the last pack.

Do I need a Pap test or blood work to start a combined pill?

Not routinely solely for contraceptive initiation in an otherwise healthy patient. CDC classifies blood pressure as the essential pre-start assessment; a pelvic exam, Pap test, routine glucose, lipids, liver enzymes, hemoglobin, thrombophilia screening, and STI/HIV labs are Class C for this purpose. Known medical problems can require more evaluation.^[4]

Is birth control the same as “bioidentical” HRT?

No. Conventional combined birth-control pills generally use ethinyl estradiol plus a progestin. Menopause HRT commonly uses estradiol in product-specific oral or transdermal doses and may require endometrial protection. They are different treatment categories with different purposes.

Why did my pharmacy give me a different brand name?

It may be a manufacturer substitution, but do not assume. Ask the pharmacist to confirm the active ingredients, strengths, active-tablet count, placebo-tablet count, and therapeutic-equivalence status.

How effective is the pill during perimenopause?

CDC estimates that about 7 in 100 users of combined hormonal contraception and 7 in 100 users of progestin-only pills become pregnant in the first year with typical use. Perimenopause lowers fertility but does not eliminate pregnancy risk, and pills do not protect against sexually transmitted infections.^[2][3]

---

The bottom line

The real question was never, “What is the lowest-dose pill?”

It is three questions:

1. 1. Do I still need birth control?
2. 2. Is estrogen appropriate for my history?
3. 3. Which ingredients, missed-pill rule, and hormone-free interval fit the problem I am actually trying to solve?

Answer those and the brand name becomes easier to sort out. Skip them and you can end up with whatever the last person handed you—a placebo week you never discussed, a price you did not expect, or a pill class that never matched your risk history.

Still not sure which HRT program is right for you? Take our free approximately 90-second matching quiz.

---

The HRT Index is the independent decision resource for online menopause and HRT care for women. Educational content only—not medical advice or a substitute for care from a licensed clinician. FDA-approved and compounded options are always labeled distinctly, and compounded products are never presented as safer than, more natural than, or equivalent to FDA-approved medication.

Sources

¹ Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.

² Centers for Disease Control and Prevention. Combined Hormonal Contraceptives: U.S. Selected Practice Recommendations, 2024.

³ Centers for Disease Control and Prevention. Progestin-Only Pills: U.S. Selected Practice Recommendations, 2024.

⁴ Centers for Disease Control and Prevention. U.S. Selected Practice Recommendations for Contraceptive Use, 2024.

⁵ Centers for Disease Control and Prevention. When Contraceptive Protection Is No Longer Needed.

⁶ The Menopause Society. Perimenopause.

⁷ Gemzell-Danielsson K, et al. Estetrol, estradiol and ethinylestradiol: Comparison of three estrogens used in hormonal contraception. 2024.

⁸ Burgin J, et al. Factors affecting contraceptive choice in women over 40: a qualitative study. BMJ Open. 2022.

⁹ U.S. Food and Drug Administration. Orange Book June 2026 Changes List. Lo Junel Fe, Teva ANDA A219324, AB-rated to Lo Loestrin Fe, approved June 22, 2026.

¹⁰ DailyMed. Lo Loestrin Fe prescribing information.

¹¹ DailyMed. Norethindrone acetate/ethinyl estradiol 1 mg/20 mcg, 21/7 regimen.

¹² DailyMed. Norethindrone acetate/ethinyl estradiol 1 mg/20 mcg, 24/4 regimen.

¹³ DailyMed. Yaz prescribing information.

¹⁴ DailyMed. Slynd prescribing information.

¹⁵ DailyMed. Opill Drug Facts label.

¹⁶ Opill. Buy Opill.

¹⁷ National Cancer Institute. Oral Contraceptives and Cancer Risk.

¹⁸ American College of Obstetricians and Gynecologists. Abnormal Uterine Bleeding.

¹⁹ GoodRx. Lo Loestrin Fe prices.

²⁰ GoodRx. Junel Fe 1/20 prices.

²¹ GoodRx. Loestrin Fe 1/20 generic prices.

²² Health Resources and Services Administration. Women’s Preventive Services Guidelines: Contraception.

²³ U.S. Department of Labor. FAQs About Affordable Care Act Implementation Part 64.

²⁴ Midi Health. Costs and coverage.

²⁵ Hers. Birth Control Online.

²⁶ Hims & Hers Support. How do I cancel my subscription?.

²⁷ Federal Trade Commission. FTC and States Act Against Hims & Hers for Deceptive and Unlawful Privacy Practices and case status.

²⁸ Sesame. Online Prescription and Refill Visits.

²⁹ Sesame. Everyday Rx.